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Examining the role of protein structural dynamics
in drug resistance in Mycobacterium tuberculosis†
Daniel J. Shaw, ‡a Rachel E. Hill,b Niall Simpson,a Fouad S. Husseini,§b Kirsty Robb,c
Gregory M. Greetham,d Michael Towrie,d Anthony W. Parker, d David Robinson, e
Jonathan D. Hirst, *b Paul A. Hoskisson *c and Neil T. Hunt *a
Antimicrobial resistance represents a growing global health problem. The emergence of novel resistance
mechanisms necessitates the development of alternative approaches to investigate the molecular
fundamentals of resistance, leading ultimately to new strategies for counteracting them. To gain deeper
insight into antibiotic–target interactions, the binding of the frontline anti-tuberculosis drug isoniazid
(INH) to a target enzyme, InhA, from Mycobacterium tuberculosis was studied using ultrafast two-
dimensional infrared (2D-IR) spectroscopy and molecular simulations. Comparing wild-type InhA with
a series of single point mutations, it was found that binding of the INH–NAD inhibitor to susceptible
forms of the enzyme increased the vibrational coupling between residues located in the Rossmann fold
co-factor binding site of InhA and suppressed dynamic ﬂuctuations of the enzyme structure. The eﬀect
correlated with biochemical assay data, being reduced in the INH-resistant S94A mutant and absent in
the biochemically-inactive P193A control. Molecular dynamics simulations and calculations of inter–
residue couplings indicate that the changes in coupling and dynamics are not localised to the co-factor
binding site, but permeate much of the protein. We thus propose that the resistant S94A mutation
circumvents subtle changes in global structural dynamics caused by INH upon binding to the wild-type
enzyme that may impact upon the formation of important protein–protein complexes in the fatty acid
synthase pathway of M. tuberculosis.
Introduction
The emergence and spread of antimicrobial resistance is
a global threat to human health. As a result of new resistance
mechanisms, current therapeutics are being rendered ineﬀec-
tive and our ability to treat common infections is threatened.
There is thus a clear need for the continuous development of
new antimicrobials for the treatment of infections, otherwise
currently routine medical procedures such as surgery and
cancer chemotherapy will become impossible and costs
associated with health care will increase. Our ability to develop
novel intervention strategies relies on a thorough under-
standing of the molecular mechanisms of resistance to inform
design of the next generation of drugs.
Mycobacterium tuberculosis, the aetiological agent of Tuber-
culosis (TB), exemplies the problem of antimicrobial resis-
tance. The World Health Organisation (WHO) estimated 10.4
million new cases of TB in 2015 with approximately 1.4 million
deaths attributed to the disease. Indeed, the WHO now clas-
sies TB as the most dangerous infectious disease aer HIV.1
Standard treatment of drug-sensitive TB is through the use of
the pro-drug isoniazid (INH) coupled with rifampicin. INH was
rst shown to be eﬀective against TB in 1952 and remains
a front-line pharmaceutical. The longevity of service, along with
incomplete or improperly-administered treatment regimens,
has contributed to the emergence of drug-resistant strains of
the bacterium, such as multi-drug resistant (MDR) and exten-
sively drug resistant (XDR)M. tuberculosis, which now represent
a global health crisis.1
Despite over 70 years of use, the in-depth molecular-level
mechanism of action, and therefore resistance, is still unclear
for INH.2–4 INH (Fig. 1(a), and ESI Scheme 1†) is a pro-drug,
requiring activation in vivo by the catalase peroxidase enzyme,
KatG. This creates an isonicotinoyl radical that reacts with NAD+
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forming the INH–NAD adduct (Fig. 1(b)) that has been shown to
be a slow, tight-binding inhibitor of the 2-trans-enoyl-reductase
enzyme (InhA) that forms part of the essential FASII mycolic
acid biosynthesis pathway in M. tuberculosis.4,5 While other
interactions of INH have been identied, the FASII pathway still
represents the most attractive pharmaceutically-validated target
for new drug development in TB.6 Interestingly, much of the
clinical resistance observed is via recessive mutations in katG,
whereas dominant mutations occur in InhA.7 InhA is a target of
both INH and the second line TB drug ethionimide, as it has
been shown that the transfer of the InhA S94A mutant allele in
M. tuberculosis is suﬃcient to confer resistance to both drugs.7
Moreover, over-expression of inhA also confers INH resistance
in M. tuberculosis.8
A number of single point mutations of InhA have been
clinically-implicated in INH resistance including I21V, I47T,
and S94A. These residues appear near to the co-factor binding
site and cause a reduction in binding aﬃnity for NADH.2,3,9
Structural studies of InhA with both the NADH co-factor and the
INH–NAD inhibitor in place have been reported5,7,10,11 and the
structure of apo–InhA has been published recently.12 These
studies show that InhA contains a Rossmann fold, a widely
distributed structural feature composed of a series of alter-
nating b-strand and a-helical segments in which the b-strands
form a single parallel b-sheet through hydrogen bonding
(Fig. 1(c)). However, virtually no global change to the enzyme
structure is found in resistant mutations, while biochemical
studies indicate that resistance is not mediated simply through
reduced aﬃnity for the INH–NAD inhibitor.2,3,9 Mutation has
been observed to aﬀect communication within the InhA homo-
tetramer, since co-factor binding becomes cooperative.3 As InhA
is part of a multi-enzyme complex in the cell, it is proposed that
INH–NAD binding inuences protein–protein interactions,
either within the InhA tetramer or with other FASII
proteins.3,13,14
These results combine to suggest that understanding the
mechanism of INH resistance in M. tuberculosis may be
informed by biophysical insight that goes beyond static struc-
tural studies. To contribute to the understanding of this
problem, we have applied ultrafast 2D-IR spectroscopy along-
side computational molecular simulations to probe the inter-
action of wild-type InhA with both the NADH co-factor and INH–
NAD inhibitor. Typically, 2D-IR is applied under circumstances
where a specic vibrational chromophore gives highly localised
insight.15–19 These studies have revealed signicant modulation
of protein structural dynamics as a result of substrate or ligand
binding,20,21 but extensive work on the InhA system suggests
that resistance may have its roots in more global processes
because binding appears to inuence protein–protein interac-
tions. To study this we explored the capability of 2D-IR to reveal
changes as a result of ligand binding to an unlabeled protein by
examining the amide I spectroscopy of the whole molecule.
Combining this with mutational studies of the S94A mutation
of InhA that is clinically-implicated in resistance, the INH-
susceptible W222A and the biologically-inactive P193A
control, which still retains a similar secondary structure to the
wild-type,22 allowed deeper insight into the mechanism of
action of INH with InhA (Fig. 1(c)). Examining the impact of
Fig. 1 Molecular structures of (a) isoniazid (INH) and (b) the adduct molecule formed between INH and NAD that is an inhibitor of InhA.4,5 (c) Left,
crystal structure of InhA (PDB 1zid),5 the color scheme runs from blue to red beginning from residue 1. The INH–NAD binding site is shown by
a yellow oval. Centre diagram shows relative positions of key residues within the INH–NAD binding site. Residues clinically-implicated in
resistance are shown using ball representations, other key residues referred to in the text are shown using a stick representation. Carbon atoms in
the INH–NAD adduct are shown in yellow; nitrogen in blue; phosphorous in orange and oxygen in red. Right, relative spatial positions of mutated
residues studied in this work to the INH–NAD adduct. S94 is shown in red, W222 in purple, P193 in orange. The NAD body of the inhibitor is
shown in white, the INH-related portion is shown in blue.
Chem. Sci. This journal is © The Royal Society of Chemistry 2017
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drug binding to its target enzyme and specic mutations in this
manner, we show that subtle structural and dynamic eﬀects
occur upon ligand binding; these begin in the Rossmann fold
co-factor binding site but extend to remote regions of the
enzyme structure. We therefore propose that this information
highlights dynamic and structural communication pathways
within enzymes that oﬀers new directions to explore in the
attempt to combat antimicrobial resistance.
Experimental
InhA preparation and enzyme assays
InhA was prepared via over-expression in E. coli and puried
using methods described previously.22 Enzyme assay data were
consistent with previous studies of InhA and have been pub-
lished elsewhere.22 To ensure that the prepared enzymes were
free of NADH prior to subsequent experiments, InhA samples
were checked aer purication and subsequent concentration
by means of UV-vis absorption. NADH presence would be
indicated by an absorption peak at 340 nm, a feature that was
absent in the UV-vis spectra recorded for our samples (see
Fig. S1†).
Sample preparation for infrared spectroscopy
Puried fractions from the InhA preparation were pooled to
obtain a starting enzyme concentration of 0.5–1 mg ml1, as
quantied by UV-vis absorption spectroscopy. These were
concentrated via sequential centrifuge ltration and buﬀer-
exchange into 200 mM deuterated sodium phosphate buﬀer,
pD 7.4 containing trace (<0.5%) sodium dodecyl sulfate (SDS) to
aid protein stabilisation at high concentration. The nal sample
concentration range was 20–30 mg ml1 (0.8 mM), suﬃcient
for all IR spectroscopy measurements. To reaﬃrm both struc-
tural integrity and activity, 1–2 ml of the enzyme was removed,
re-diluted to 2 mM, and assayed.22 The highly concentrated
InhA was also checked for consistency with low concentration
samples via UV-vis spectroscopy. Conrming activity at 0.8 mM
was challenging due to the large absorbances of the assay
constituents, but when InhA was added to 150 mM NADH and
50 mMDD–CoA, an almost immediate drop to zero of the NADH
absorbance was observed, indicating that the InhA was active at
0.8 mM concentration.
For all IR measurements, the samples were held between two
CaF2 windows separated by a spacer of 50 mm thickness.
Samples were nely adjusted with amounts of deuterated buﬀer
(without additional SDS) to provide peak absorptions of 0.15–
0.2 at the amide I central frequency of 1647 cm1. FT-IR
measurements of apo–InhA at 0.8, 0.4 and 0.27 mM concen-
tration were made and could be scaled and overlaid to within
the signal to noise level of the FT-IR instruments, providing
additional conrmation that no InhA aggregation takes place
under these conditions.
Apo–InhA spectra were collected at a concentration of
0.8 mM for all mutants described in the main article. To obtain
the 2D-IR data for InhA with NADH present, 20 ml volumes of
0.8 mM InhA and 0.8 mM NADH were mixed and measured
45–60 minutes aer mixing. InhA samples inhibited by the
INH–NAD complex were prepared based on previously pub-
lished procedures,4,5 but due to the extremely high NADH
concentration that direct scale-up would have required, which
would lead to large convolutions in the InhA amide I spectral
response, they were adapted for a 1 : 1 : 1 mixture of InhA,
NADH and INH all at 0.8 mM concentration. The mixture was
incubated overnight at room temperature along with 1.6 mM of
MnCl2 under N2 atmosphere to prevent H–D exchange. The
biochemical pathway for producing INH–NAD is shown in the
ESI (Scheme 1†).5
Infrared spectroscopy
The method for obtaining 2D-IR spectra has been described
previously.23 Briey, the FT-2D-IR method was employed, which
uses a sequence of three mid-IR laser pulses arranged in
a pseudo pump-probe beam geometry.24,25 The pulses were
generated by the ULTRA laser system consisting of a Ti:sapphire
laser pumping a white-light seeded optical parametric amplier
(OPA) equipped with diﬀerence frequency mixing of the signal
and idler. Mid IR pulses with a temporal duration of <100 fs;
a central frequency of 1650 cm1 with a bandwidth of
400 cm1 were employed.26 All reported spectra were obtained
using a waiting time of 250 fs and parallel pump-probe polari-
zation direction. Each data point in the 2D-IR spectra displayed
results from the averaged acquisition of 12 000 laser shots. It
has been established that the direct contribution of either
NADH or INH–NAD to the 2D-IR spectra was negligible at the
concentrations studied and therefore any changes reported are
due to the eﬀect of ligand binding on the enzyme.27,28
Computational modelling
Four diﬀerent variants of InhA from M. tuberculosis were
studied using MD simulations and network models of the one
exciton Hamiltonian in order to investigate the eﬀect of muta-
tion and ligand binding on the structure and dynamics of the
protein. The four variants chosen were the wild-type enzyme in
complex with NADH (PDB code 2aq8 (ref. 10)) and with INH–
NAD (PDB code 1zid5); the S94A mutant in complex with NADH
(PDB code 4dti11) and with INH–NAD (PDB code 2nv6 (ref. 7)). In
the case of both structures with the INH–NAD inhibitor bound,
the reported structures feature a mutation at residue 2 and not
all were complete sequences in the protein databank with early
residues missing. These variations have been accounted for in
the residue numbers reported from calculations. It is noted that
InhA exists as a homotetramer in vivo, but the crystal structures
are for the monomeric unit only and these were studied in the
simulations. Extensive simulations of the tetramer have
revealed no correlated motions over 150 ns among the four
pockets, supporting the assumption that their movements can
be treated as independent.29
MD simulations and IR calculations
MD simulations were carried out starting from each of the four
crystal structures of InhA listed above. Simulations of the apo-
form were modelled by excising the co-factor or inhibitor
This journal is © The Royal Society of Chemistry 2017 Chem. Sci.
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prior to performing simulations. The structures were mini-
mised using the steepest descent algorithm and solvated in
a truncated octahedron of TIP3P water,30 ensuring a minimum
distance of 10 A˚ between the protein and the edge of the water
box. A simulation was initially carried out with the protein
atoms restrained for 50 ps in order to “soak” the peptide
backbone in the water molecules. Subsequently, an equilibra-
tion period of 5 ns was carried out in an NVT ensemble at 300 K.
Periodic boundary conditions and PME electrostatics31 were
used with a cut oﬀ of 10 A˚ and the Verlet scheme32 to allow GPU
acceleration of the simulation in GROMACS.33,34 Heavy atom-
hydrogen bonds were constrained using the LINCS algo-
rithm,35,36 permitting a 2 fs time step size. Production dynamics
were carried out using the same parameters for 20 ns, with
snapshots saved every 1 ps. The ligand simulations were set up
with the CHARMM-GUI37 using the CHARMM36 forceeld.38
For simulations of the inhibited enzymes, parametrisation of
INH–NAD was performed using the CHARMM Generalised
Forceeld39 and the SwissParam server.40 For simulations of the
enzyme with the co-factor bound (based on PDB: 2aq8 (ref. 10)
and 4dti11), the N-terminal glycine was patched using the GLYP
patch. All four structures were solvated as for the apo-enzyme
simulations. The solvated structures underwent 30 000 steps
of minimisation using the steepest descent and the Adopted
Basis Newton–Raphson schemes. This was followed by a 10 000
step minimisation using the conjugate gradients scheme and
a 50 ps dynamics run carried out to ensure no bad contacts
between the enzyme and ligand. The production dynamics were
performed using GROMACS in order to take advantage of the
GPU acceleration. All other simulation details were the same as
for the simulations of the apo-forms.
Twelve independent simulations were performed for each
system. FTIR spectra in the amide I region were computed using
an exciton approach.41,42 A one-quantum exciton Hamiltonian
was constructed, with the oﬀ-diagonal elements representing
interaction energies between local amide I vibrations computed
using the transition dipole coupling model43 except for the
nearest–neighbour interactions. The latter were taken from
a look-up table of couplings derived from DFT calculations on
a systematic set of conformations of a dipeptide.44 Network
graphs45 generated using the open-source code gephi46 were
used to visualize the inter–residue interactions.
A scaled two-quantum Hamiltonian, comprising two-
quantum local states and coupling, was constructed41,42 from
the one-quantum Hamiltonian matrix elements, using a modi-
ed version of the peptide C programme of Hamm and Zanni.19
This programme was used to compute the 2D signal using 250
snapshots from a single representative trajectory. In previous
work,42 we found that for the small protein ubiquitin, where
more extensive exploration of convergence was tractable, 2D-IR
spectra computed with 200 uniformly sampled snapshots gave
a computed spectrum very similar to that computed with 2000
snapshots. The non-zero two-quantum Hamilton matrix
elements are:
Hij,ij ¼ Hi,i + Hj,j  di,jD
Hii,jk ¼ O2 (Hi,jdi,k + Hi,kdi,j); ii s jk, js k
Hij,jk ¼ Hi,k(di,j + dj,k); i s k
The diﬀerent sites (local amide I vibrations) are indexed by i,
j and k; d is the Kronecker delta. The anharmonicity, D, was
taken to be 16 cm1.47 The computed 2D signal is the sum of the
rephasing and nonrephasing components. It is assumed that
the transition dipoles scale like a harmonic oscillator from the
fundamental to the overtone and that the dephasing times of
the 0/ 1 and 1/ 2 transitions are equivalent.
Results
For the wild-type enzyme and each of the mutations studied,
activity assays were carried out both in the presence and
absence of the INH–NAD inhibitor to establish the viability of
the enzyme samples. This data has been reported elsewhere22
but, briey, the results are consistent with previous studies of
the wild-type and S94A mutation, showing an aﬃnity for NADH
in the mM range while the INH–NAD inhibitor binds with nM
aﬃnity.2,3,9 It has been shown that the S94A mutation results in
a reduction in aﬃnity for NADH (though this remains in the mM
range) but that the mutation has little impact upon INH–NAD
binding.2,3,9 In the case of the additional W222A mutation
studied here, this showed a slightly reduced activity, with
respect to NADH turnover, in relation to the wild-type enzyme
(60%) and was found to be inhibited by INH–NAD.22 The
P193A mutation was found to have negligible activity with
respect to both NADH and INH–NAD binding and will therefore
provide a negative control for the spectroscopy data.
To place the results in a structural context, the InhA struc-
ture features a Rossmann fold co-factor binding site consisting
of two b-strands (designated str-4 and str-5) anking the helix
(hel-5) which contains the K165 and Y158 residues that have
been shown to be key to InhA function (Fig. 1(c)).2,9,48 Two
further a-helices (hel-4 and hel-6) complete the binding
pocket.48,49 In studies of InhA with co-factor and substrate
bound it has been shown that the residues 195–207, which
contribute to hel-6 and form the substrate binding loop (SBL,
Fig. 1(c)), can undergo a disorder–order transition that may
inuence substrate binding.2
FTIR spectroscopy shows that no gross structural changes
occur upon ligand binding, but the 1620 cm1 part of the
amide I band of wild-type InhA increases in amplitude
A representative selection of the FT-IR spectra for the apo
enzymes and enzymes with co-factor or inhibitor present are
shown in Fig. 2. In light of the availability of crystal structures
for the wild-type enzyme (Fig. 2(a)) and S94A mutation
(Fig. 2(b)), we will focus on these in the discussion, using the
P193A mutant (Fig. 2(c)) as a control. The data for the W222A
mutant is shown in Fig. 2(d) for comparison. In these gures,
the red trace represents the apo-enzyme; blue represents the
enzyme with the NADH co-factor present and green the enzyme
with the INH–NAD inhibitor present.
Chem. Sci. This journal is © The Royal Society of Chemistry 2017
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In the amide I region of the IR spectrum, a broad absorption
band is observed in each case centred near 1640 cm1 as would
be expected for an enzyme with a secondary structure that is
largely a-helical in composition.15–19 The similarity of the
spectra shows that no major change in structure of the enzyme
is occurring in any of the samples. The data in Fig. 2 has been
normalised to the peak absorption in order to compare the
relative shapes of the absorption bands. In the case of the wild-
type enzyme (Fig. 2(a), red), a slight broadening of the amide I
lineshape is observed upon binding of the NADH co-factor
(Fig. 2(a), blue) and a shoulder is observed on the low-
frequency side of the band located near 1620–1630 cm1. The
latter is shown by an arrow in Fig. 2(a) and becomes more
pronounced when the INH–NAD inhibitor is bound to the
enzyme (Fig. 2(a), green). In the case of the apo-forms of the
S94A mutation and P193A control (Fig. 2(b) and (c), red) a slight
asymmetry is observable on the low frequency side of the line-
shape in the position of the 1620–1630 cm1 feature observed in
the wild-type enzyme spectra. This is slightly more pronounced
in the P193A case (Fig. 2(c), red). However, the feature does not
change signicantly upon either co-factor or inhibitor binding
in either mutation in relation to the signal to noise level
achievable at the concentration studied. It is important to stress
that, under the conditions described for these measurements,
the size of the absorption due to the co-factor or inhibitor was
negligible and that any changes observed are occurring to the
protein as a result of binding. No aggregation of the protein was
observed. The results for the W222A mutant most closely
resemble those of the wild-type enzyme (Fig. 2(d)).
2D-IR spectroscopy reveals an oﬀ-diagonal peak with an
amplitude that correlates with biological activity
Ultrafast 2D-IR spectra of apo–wild-type InhA and wild-type
InhA with co-factor and inhibitor bound are shown in
Fig. 3(a–c) along with the corresponding spectra for the S94A
mutant (Fig. 3(d–f)) and P193A control (Fig. 3(g–i)). The spectra
recovered are broadly similar in all cases, as would be expected
for largely similar enzymes, consisting of a negative feature
(blue) located on the spectrum diagonal with a positive feature
(red) shied to lower probe frequency by around 20 cm1. Both
components of the spectrum are strongly elongated along the
diagonal. The negative feature has its centre near 1640 cm1 on
the spectrum diagonal and can be assigned to the v ¼ 0–1
transition of the amide I mode of the enzyme, as observed in the
FT-IR spectrum. The red feature is assigned to the amide I v ¼
1–2 transition; the shi of this feature along the probe axis
arises from the anharmonicity of the potential surface and is
consistent with the accepted value of 16 cm1 for the amide I
mode.47
It can be seen from Fig. 3(a) that the amide I v ¼ 0–1 band is
not a simple feature and that three individual components
occur along the diagonal located near 1620, 1640 and 1660 cm1
(see guidelines and yellow arrows in Fig. 3(a)). Fitting of the FT-
IR spectra in Fig. 2 revealed that these components can also be
seen in the absorption spectra (Fig. S2†) but they are better-
resolved by the 2D-IR methodology, which accentuates narrow
features due to the dependence of the 2D-IR signal upon the
fourth power of the transition dipole moment.47 The features
near 1640 cm1 and 1620 cm1 can be assigned, based on
previous work on protein IR spectroscopy, to a-helix and b-sheet
components of the secondary structure respectively. The
1660 cm1 feature is attributable to b-turn components.
In the oﬀ-diagonal regions of the 2D-IR spectra in Fig. 3, the
most prominent feature links the diagonal peaks near 1620 and
1640 cm1. This is much more clearly resolved in cross-section
(see below) but is marked by black arrows in Fig. 3 and was
observed in each of the enzymes studied. Oﬀ-diagonal features
in 2D-IR spectra generally indicate the presence of vibrational
coupling, energy transfer or chemical exchange.15–19 Given the
short waiting time at which the spectra were recorded (250 fs),
Fig. 2 FTIR spectra of (a) wild-type InhA (b) S94A–InhA, (c) P193A–
InhA and (d) W222A–InhA. In each panel red corresponds to the apo-
enzyme, blue to the enzymewith NADH cofactor present and green to
the enzyme with the INH–NAD inhibitor present. The arrow in (a)
marks the increased amplitude near 1620–1630 cm1 observed upon
binding of the co-factor and inhibitor to the wild-type enzyme dis-
cussed in the text. All spectra are normalised to the peak of absor-
bance. Uncertainty due to measurement error in each individual
spectrum is indicated by the width of the line.
This journal is © The Royal Society of Chemistry 2017 Chem. Sci.
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the eﬀects of energy transfer and exchange are assumed to be
negligible and the likely assignment in this case is to vibrational
coupling patterns associated with residues involved in the
b-sheet element of the InhA structure.50
In order to more clearly diﬀerentiate between the oﬀ-
diagonal features observed in Fig. 3, cross sections through
the 2D-IR spectra were taken at a pump frequency of 1620 cm1
for the wild type (Fig. 4(a)), S94A mutant (Fig. 4(b)), P193A
control (Fig. 4(c)) andW222A (Fig. 4(d)) in the apo-enzyme (red),
enzyme with co-factor (blue) and enzyme with inhibitor (green)
forms. Here, the diagonal (v ¼ 0–1) peak at 1620 cm1 and the
oﬀ-diagonal feature near 1640 cm1 are resolved; vertical
dashed lines in the gure mark the positions. In the case of the
wild-type enzyme (Fig. 4(a)), when NADH is present (Fig. 4(a),
blue), the oﬀ-diagonal feature grows in size in comparison to
the apo-enzyme (Fig. 4(a), red). Addition of INH–NAD (Fig. 4(a),
green) also increases the amplitude of the oﬀ-diagonal feature,
but the peak also appears broadened and shied slightly to
higher wavenumber in comparison to that with NADH alone.
The changes in the oﬀ-diagonal peak were quantied by
tting the 1620 cm1 cross-section of the 2D-IR spectra to
Gaussian lineshape functions. The results of the process are
shown in detail in Table S1 and Fig. S3.† To account for varia-
tions between individual measurements arising from uctua-
tions in laser intensity or concentration, we focus on the ratio of
the amplitudes of the oﬀ-diagonal to the diagonal peaks in this
cross-section. Applying this analysis to the wild-type enzyme
data shows that, upon binding of NADH, the oﬀ-diagonal
feature increases in amplitude from 21% of the diagonal v ¼
0–1 feature to 37%; this increases further to 42% for the
Fig. 3 2D-IR spectra of (a–c) wild-type InhA (d–f) S94A–InhA and (g–i) P193A–InhA. In each case, spectra are shown for (a, d, g) the apo-
enzyme, (b, e, h) the enzymewith NADH cofactor present and (c, f, i) the enzymewith the INH–NAD inhibitor present. Scale bars (S2D-IR) show the
magnitude of the 2D-IR signal, a total of 20 contour lines are shown at evenly-spaced 5% intervals of the maximum signal shown. Yellow arrows
in (a) mark the position of individual components of the v ¼ 0–1 diagonal peak discussed in the text. The black arrows show the position of the
oﬀ-diagonal feature discussed in the text.
Chem. Sci. This journal is © The Royal Society of Chemistry 2017
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inhibited wild-type enzyme. The tting results also show that
the oﬀ-diagonal feature is centred near 1630 cm1 and suggests
that a shi to higher frequency and a broadening occurs upon
binding the co-factor, with a further shi and broadening upon
inhibition. However, the changes in peak position and width
are of the order of 2–3 cm1, comparable with the resolution of
the instrument and so the main result is a change in amplitude
of the feature upon binding of the co-factor followed by
a further increase upon inhibition. The fractional increases in
the ratio of the amplitude of the oﬀ-diagonal peak to the diag-
onal feature derived from lineshape tting are displayed in
Fig. 5(a) for binding of the co-factor (blue) and changing the co-
factor to the inhibitor (brown). For the wild-type enzyme, the
increase in oﬀ-diagonal peak amplitude ratio from 21% to 37%
gives a fractional increase of 1.76 in Fig. 5(a), a further increase
by a factor of 1.14 is indicated by the curve tting analysis upon
changing NADH to INH–NAD (37–42%).
When studying the amide I band of the whole enzyme
molecule, changes to the 2D-IR signal caused by binding of
a ligand that has been shown not to aﬀect the structure of the
molecule in a signicant manner are likely to be subtle. It is
thus important to put the results obtained for the wild-type
enzyme into context by examining the cross sections through
the 2D-IR spectra of the P193A control, which showed negligible
activity or response to INH–NAD in enzyme assays.22 The same
oﬀ-diagonal feature is present in the P193A apo-enzyme
(Fig. 4(c)) but it does not change in terms of amplitude or
position/width in response to addition of either NADH or INH–
NAD (Fig. 4(c), Table S2†). Crucially, the three spectral slices
overlap to within the noise level of the measurement, such that
they are indistinguishable for the control sample (Fig. 4(c)).
Using the same curve-tting approach as applied to the wild
type enzyme data shows that the ratio of the amplitude of the
oﬀ-diagonal feature to that of the diagonal peak varies by less
than 1% across the three samples (Table S2,† Fig. 5(a)). This
gives us condence in the validity of the subtle spectral changes
observed upon inhibition of the wild-type enzyme and we use
bars on the data in Fig. 5(a–d) to give an indication of the
observed sample-to-sample variation in the results because, for
protein samples, these variations far outweigh the measure-
ment errors in a single sample. It is noted that the molecular
impact of introducing INH to the system is the addition of
a relatively small aromatic ring to the large NAD molecule and
so a larger impact upon the enzyme spectrum would be antic-
ipated to occur upon cofactor binding rather than during the
change from cofactor to inhibitor binding, as we observe.
Extending the study to the S94Amutant (Fig. 4(b), red) shows
that the apo-enzyme spectrum also contains the same oﬀ-
diagonal feature, but it is considerably lower in amplitude
than that of the wild-type apo-enzyme (12% of the diagonal v ¼
0–1 feature, Table S3†)). Upon binding of NADH, this feature
again increases in size to 19% of the v ¼ 0–1 peak amplitude
(Fig. 4(b), blue and Fig. 5(a)). In the case of the S94A mutant,
binding of the inhibitor complex results in similar value for the
oﬀ-diagonal peak amplitude as observed for the co-factor; the
curve tting analysis indicates a very small amplitude increase
to 21% upon inhibition (Fig. 5(a)). Once again a slight broad-
ening and shi to higher frequency of 2–3 cm1 is also indi-
cated. Although the changes in the oﬀ-diagonal peak are more
subtle than observed for the wild-type enzyme, they are larger
than the variation between spectra observed for the P193A
control.
In the case of the W222A mutation (Fig. 4(d)), which behaved
in a similar manner to the wild-type enzyme in assays, though
with reduced activity, a similar trend is observed in the 2D-IR
spectra in this mutant to the wild-type enzyme. The oﬀ-
diagonal feature increases in amplitude from 21 to 26% and
30% of the v ¼ 0–1 diagonal feature upon binding of the co-
factor and inhibitor respectively (Table S4,† Fig. 5(a)).
Discussion
The oﬀ-diagonal feature linking the parts of the diagonal line-
shape located at 1620 and 1630–40 cm1 in the 2D-IR spectrum
is responsive to point mutation and co-factor or inhibitor
binding. It is widely accepted that very little macroscopic
change in the structure accompanies these processes and so the
Fig. 4 (a–c) Slices through 2D-IR spectra at a pump frequency of
1620 cm1 of (a) wild-type InhA (b) S94A–InhA (c) P193A–InhA and (d)
W222A–InhA. Red: apo-enzyme; blue: NADH cofactor bound; green:
INH–NAD inhibitor bound. Insets in (a–c) show expanded regions near
the oﬀ-diagonal feature discussed in the text. Uncertainty due to
measurement error in each individual spectrum is indicated by the
width of the line.
This journal is © The Royal Society of Chemistry 2017 Chem. Sci.
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2D-IR data is potentially indicative of a new molecular response
to ligand binding.5,7,10,11
We evaluate the signicance of this result by comparing the
spectroscopic data to the results of biochemical assays of
enzyme performance, beginning by considering the change in
amplitude of the oﬀ-diagonal feature upon NADH binding. It is
established that point mutations can inuence the aﬃnity of
InhA for NADH and the activity of each mutant relative to the
wild-type enzyme is shown in Fig. 5(b) (blue bars).22 In Fig. 5(c)
the change in the oﬀ-diagonal peak amplitude upon co-factor
binding is compared to enzyme activity and another measure
of enzyme performance, the eﬃciency, determined as kcat/KM
via a standard Michaelis–Menten analysis.22 The striking result
is that the amplitude change of the oﬀ-diagonal peak in the
spectrum of each mutant upon co-factor addition correlates
well with measurements of enzyme activity Fig. 5(c). The level of
variation for W222A is greater than the wild-type or the S94A
mutant, but this is also true of the assay data, which shows
greater variance between activity (determined from initial
reaction rates) and eﬃciency parameters, suggesting a more
complex biochemical mechanism may be operational in this
mutant. Overall, the correlation of the amplitude of the oﬀ-
diagonal feature with co-factor binding is strongly indicative
of a relationship between spectroscopy and enzyme function.22
In the case of all mutants studied except the control,
a further, smaller, increase of the oﬀ-diagonal peak was
observed upon changing the co-factor (NADH) to the inhibitor
(INH–NAD). Comparing spectroscopic and biochemical assay
data suggests that the change in the amplitude of the oﬀ-
diagonal feature upon moving from co-factor binding to inhi-
bition closely follows the impact of the inhibitor upon enzyme
function. Fig. 5(a) and (b) show that the largest change in the
shoulder amplitude upon inhibition occurs for the INH-
susceptible wild-type and W222A mutants, whereas that for
S94A is smaller (Fig. 5(a)), consistent with the reduced inhibi-
tion experienced by this resistance-implicated mutation
(Fig. 5(b)). The correlation is shown by Fig. 5(d), which
compares the level of inhibition of each enzyme with the change
in the oﬀ-diagonal peak amplitude, where the two trends follow
each other very closely. This demonstrates clearly that inhibi-
tion has an additional molecular impact over and above co-
factor binding that is detected by 2D-IR spectroscopy. That
Fig. 5 Comparisons of enzyme assay data with amplitude changes of the oﬀ-diagonal peak from Fig. 4. (a) Fractional change of the amplitude of
the oﬀ-diagonal peak at [pump, probe ¼ 1620 cm1, 1640 cm1] on binding co-factor (blue) and changing co-factor to inhibitor (brown) (b)
enzyme assay activity results (blue) given as percentage of wild-type enzyme activity. Inhibition values (brown) show activity following inhibition
as a percentage of the value for the uninhibitedmutant.22NB quoted S94A data from ref. 22 were obtained using higher INH–NAD concentration
than wild type and W222A so inhibited activity represents a lower limit. (c) Compares the change in amplitude of the oﬀ-diagonal peak upon co-
factor binding (brown) with enzyme activity (blue) and eﬃciency (green) derived fromMichaelis–Menten analysis.22 (d) Directly compares the oﬀ-
diagonal peak amplitude change upon changing co-factor to inhibitor (brown) with the level of inhibition blue, the inverse of the inhibited activity
data from (b). NB quoted S94A data from ref. 22 were obtained using higher concentration of inhibitor than wild type and W222A so inhibition
represents an upper limit. Error bars on 2D-IR data indicate the spread of sample-to-sample variation from triplicate measurements, those on
biological data are taken from ref. 22.
Chem. Sci. This journal is © The Royal Society of Chemistry 2017
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the region of the spectrum aﬀected is the same in both co-factor
and inhibitor binding implies that the molecular origin may be
similar, perhaps as would be expected given that the same
binding site is accessed by both co-factor and inhibitor, but,
crucially, the extent of the spectroscopic eﬀect diﬀers.
Before turning to the modelling aspects of this study it is
important to consider the possible origins of the oﬀ-diagonal
component that we observe in the 2D-IR spectra of InhA. As
described above, it is clear that the feature is assignable to
vibrational coupling between an excited mode, with a transition
frequency of 1620 cm1, and others with a transition frequency
of 1630–1640 cm1. The 1620 cm1 mode is assigned to the
nperpendicular mode of a b-sheet secondary structure element in
which oscillators that line up across the strands couple strongly
through hydrogen bonding.50 The nature of the modes at 1630–
1640 cm1 are less clear however and we discuss three possi-
bilities as to the assignment of these modes. The rst possibility
is that the features are due to coupling patterns within the
b-sheet. Although the nperpendicular mode is prominent in
a b-sheet spectrum, many other modes contribute and some of
these have frequencies in the 1630–1640 cm1 region of the
spectrum.19 In an innite, well-ordered anti-parallel b-sheet
these are forbidden by symmetry and a second nparallel mode is
observed near 1680 cm1. In reality, these weaker modes are
visible leading to a continuum feature, arising from an assort-
ment of low intensity transitions, being observed between the
strong 1620 and 1680 cm1 modes. The 2D-IR spectrum of an
antiparallel b-sheet has been reported to show coupling
patterns linking the main nperpendicular and nparallel transitions to
weaker modes located near 1630–1640 cm1, giving the 2D-IR
spectrum a characteristic ‘Z’-shape signature.50
The InhA co-factor binding site features a parallel b-sheet
and this leads to a change in the mode structure expected. The
nperpendicular mode is still present but the 1680 cm
1
nparallel
transition is not observed and is predicted to occur at a much
lower frequency, below 1640 cm1, in the parallel case.51 A
similar ra of low intensity modes are also expected to be visible
in a non-perfect parallel b-sheet and so the oﬀ-diagonal feature
shown in Fig. 3 is consistent with changes in couplings
involving the nperpendicular mode of the parallel b-sheet of the
Rossmann fold. A better-dened b-sheet arising from binding
could increase the size of the b-sheet signal and potentially
increase the visibility of the oﬀ-diagonal component linking to
the nparallel mode at frequencies below 1640 cm
1. The localised
position and relatively narrow width of the oﬀ-diagonal feature
indicated by tting of slices through the 2D-IR spectrum along
with the increased 1620 cm1 amplitude in the IR absorption
data (Fig. 2(a)) would seem to support assignment of this to
a well-dened vibrational mode.
The second possibility is that an increase in disorder within
the b-sheet upon co-factor binding leads to the weaker modes
gaining prominence relative to the diagonal peak by relaxing
the symmetry-forbidden nature of the transitions. The localised
and narrow nature of the oﬀ-diagonal peaks observed and the
increase in the b-sheet signal at 1620 cm1 observed in the
absorption spectra tends to favour the increased integrity
argument over this explanation however. The fact that
a signicant increase in the enzyme melting temperature has
been reported upon binding of both NADH and INH–NAD also
contradicts this argument.12 This was interpreted as an
increased stabilisation of the structure and would be consistent
with a general increase in coupling interactions within the
molecule rather than increased disorder.
The third possibility that may cause altered vibrational
coupling patterns of the nperpendicular b-sheet mode is changes in
coupling of b-sheet modes to a-helix modes, which typically
occur near 1635 cm1. As the central feature of the InhA co-
factor binding pocket is the b–a–b Rossmann fold, this
assignment would seem reasonable, though the tting results
suggest that the feature may occur at too low a frequency to be
purely due to b–a coupling.47
Overall, the data are consistent with a picture in which binding
of the co-factor to all but the inactive P193A mutant leads to an
enhanced b-sheet spectral contribution, potentially with
increased oﬀ-diagonal components arising from the b-sheet itself
or interactions between the b-sheet and a-helix elements of the
Rossmann fold. Further changes are caused by inhibition.
Molecular modelling and spectra calculations assign oﬀ-
diagonal peak to changes in vibrational coupling that
permeate the InhA structure
We now refer to modelling studies to shed more light on these
scenarios, but it is clear from experiment that the b-sheet is
central to the spectral changes and is altered by binding. This is
consistent with its prominent place in the co-factor binding site
of InhA. It is however noted that, given the structural complexity
of the co-factor binding pocket, multiple mechanisms may
contribute, for example increased b-sheet–a-helix coupling
accompanying an enhanced b-sheet signal.
It is important rst to establish that the proposed assign-
ment of the spectroscopic signatures to changes in inter–
residue couplings within the structure of the enzyme is
reasonable. For this, atomistic simulations were used to calcu-
late one-exciton Hamiltonian matrices and coupling interac-
tions following MD simulations to reach an equilibrated
structure of the ligand bound and ligand-free complexes. These
were then used as the basis to calculate a two-quantum
Hamiltonian and simulated 2D-IR spectra, examples of which
are shown in Fig. 6. The simulated spectra clearly reproduce the
main features of the experimental data in terms of the location
of the v ¼ 0–1 and v ¼ 1–2 components of the signal.
The general shapes of the 2D features match well with the
experimental data (Fig. 3). Importantly, the presence of the oﬀ-
diagonal component linking a pump frequency of 1620 cm1
with a probe frequency of 1640 cm1, as observed in the
experimental data, is also present (marked by the intersection of
the black dashed lines in Fig. 6) suggesting that the simulations
are also reproducing the ner structure of the 2D-IR signal well.
Comparison of the simulated spectra for the wild-type enzyme
with inhibitor bound (Fig. 6(a)) and the wild type enzyme with
the inhibitor excised (Fig. 6(b)) shows that the oﬀ-diagonal peak
is smaller in magnitude the latter case (indicated by a lighter
orange colour at the intersection point of the black guidelines),
This journal is © The Royal Society of Chemistry 2017 Chem. Sci.
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as was observed in the experimental data. This is displayed
more clearly by the bar graph in Fig. 6(c), which shows the
distribution of oﬀ-diagonal peak amplitudes predicted by 250
individual simulation snapshots. The shi of the graph to larger
(negative) values upon binding is clear.
In the simulations of the corresponding spectra for the S94A
mutant, the behaviour of the oﬀ-diagonal peak was also in good
agreement with experiment, showing an increase in amplitude
upon moving from the apo to the inhibited enzyme. The
simulated spectra are shown in Fig. 6(d) and (e), the distribu-
tion of amplitudes from the simulation snapshots is shown in
Fig. 6(f).
Contributions to the simulated 2D-IR spectra from the wild
type and S94A mutation can be amplied further by exploiting
the diﬀerent responses of the diagonal and oﬀ-diagonal 2D-IR
signals to polarisation in order to enhance the oﬀ-diagonal
peaks.19 The result of plotting the simulated hZZZZi-hZXXZi
signal, which has been shown to suppress diagonal peaks, is
shown in Fig. S4† where the oﬀ-diagonal peaks appearing
between the 1620 and 1640 cm1 are clear and provide further
evidence of the contribution from coupling of b secondary
structural elements in the region of the spectrum observed in
experiments.42
Fig. 6 Simulated 2D-IR spectra of InhA. (a) Simulated spectrum based on the structure of the wild type enzymewith the inhibitor complex bound
(PDB: 1zid5) (b) simulated 2D-IR spectrum showing the eﬀect of excising the inhibitor ligand from the structure used to produce the spectrum in
(a). (c) Bar graph showing distribution of oﬀ-diagonal peak amplitudes for inhibited (dark blue) and apo-forms of the wild-type enzyme calculated
from 250 individual simulation snapshots. The shift to larger (negative) predicted peak amplitudes upon inhibition is clear. (d) Simulated spectrum
based on the structure of the S94Amutant with the inhibitor complex bound (PDB: 2nv6 (ref. 7)) (e) simulated 2D-IR spectrum showing the eﬀect
of excising the inhibitor ligand from the structure used to produce the spectrum in (c). Black dashed lines mark the position of the oﬀ-diagonal
feature discussed in the text. (f) Bar graph showing distribution of oﬀ-diagonal peak amplitudes for inhibited (dark blue) and apo-forms of the
S94A mutant calculated from 250 individual simulation snapshots.
Chem. Sci. This journal is © The Royal Society of Chemistry 2017
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Having established that the simulations reproduce the
experimental data, it is instructive to explore the outcomes of
the simulations in more detail. The results of calculating inter–
residue couplings are displayed in Fig. 7 as network coupling
maps46 where each node represents a residue; lines linking
residues indicate a coupling interaction and the thickness of
the line indicates the magnitude of the coupling. A comparison
of the network maps produced for the enzymes using this
approach shows excellent correlation with the crystal structures
and the overall similarities between the PDB structures and
the network model indicates that the parameters used in the
models are of suﬃcient quality to draw conclusions about the
structure and dynamics of the protein from the models.
Elements due to the coupling patterns associated with residues
participating in the a-helices and b-sheet are visible and it is
clear that the former are dominated by near-neighbour
couplings while the latter feature more couplings between
strands in the sheet as would be expected.
The coupling networks are broadly similar for both apo-wild-
type enzyme (Fig. 7(a)) and the apo–S94A mutant (Fig. 7(b)),
indicating that the two are fundamentally similar in the
absence of the binding ligand (either co-factor or inhibitor),
consistent with observations from FT-IR data (Fig. 2) that the
mutations do not cause large disruptions in the overall struc-
ture of the protein. A diﬀerence interaction map (Fig. 8) shows
this more quantitatively than the network schematic. In Fig. 8,
points along the diagonal represent amino acid residues. Black
points above the diagonal, linking two residues, indicate spatial
proximity of those residues while the region below the diagonal
shows changes in couplings between the two structures that are
compared. The change in coupling is shown via the colour-
scale. Only couplings between residues separated by more
than four positions in the amino acid sequence (i, i + 4) are
shown in order to emphasise couplings within or between
secondary structure elements. Key regions of the InhA structure
are highlighted by coloured boxes; orange shows range of resi-
dues encompassing the cofactor binding site; red indicates
residues proximal to the NADH cofactor; blue shows the
substrate binding loop. It is clear from Fig. 8(a) that few
signicant diﬀerences in couplings are noted between the apo
Fig. 7 Network graphs depicting the one-quantum exciton Hamiltonian inter–residue couplings. (a) apo wild-type without inhibitor (PDB: 2aq8
(ref. 10)); (b) apo S94A mutant without inhibitor (PDB: 4dti11); (c) wild-type with inhibitor (PDB: 1zid5); (d) S94A mutant with inhibitor (PDB: 2nv6
(ref. 7)). The crystal structure (PDB: 1zid5) is shown as a ribbon diagram in the centre for comparison; the colours of residues are consistent across
the ﬁgure but small changes in orientation of the network maps are present. Each node represents a residue; lines linking residues indicate
a coupling interaction and the thickness of the line indicates the magnitude of the coupling, for further details see text.
This journal is © The Royal Society of Chemistry 2017 Chem. Sci.
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forms of the wild type enzyme and S94A mutant, as shown by
the small number of points below the diagonal of the plot.
Introduction of the co-factor or INH–NAD inhibitor into each
of the enzyme structures does not signicantly change the
structure observed (Fig. 7(c) and (d)), but the couplings are
aﬀected by inclusion of the ligand (Fig. 8(b)). In particular, the
average coupling strengths are seen to increase in the inhibited
enzyme and strong couplings are observed between residues in
the Rossmann fold binding site with either co-factor or inhib-
itor bound. Importantly, given our results, greater variation in
the coupling interactions between the wild-type and the S94A
mutant were observed upon inhibitor binding; the impact of
inhibition being reduced in the S94A mutant in comparison to
the wild-type enzyme. Fig. 8(b) shows the diﬀerence map
comparing the couplings in the inhibited wild type enzyme and
S94A mutant and it is clear that, not only does the number of
coupling changes increase in the wild-type enzyme, but that
they permeate across much of the molecule as well as directly
inuencing the co-factor binding region and substrate binding
loop. This suggests that the inhibitor has an eﬀect on the wild
type enzyme that is not replicated in the S94A mutant.
Overall, the one-exciton Hamiltonian calculations show
a general “relaxation” of the 3D structure for all structures
studied (wild type and S94A, each with NADH co-factor and
INH–NAD inhibitor bound) upon removal of the ligand. Smaller
coupling values are observed in the apo form and there are
fewer strong interactions between residues in the co-factor
binding site in simulations of the apo-enzyme, suggesting
these residues sit further apart than when the ligand is present.
When a ligand is bound, larger diﬀerences in the shorter range
interactions (i, i + 4 or less) occur and larger couplings are
observed in general, supporting the idea of generally stronger
inter-residue interactions and correlate with the higher experi-
mental melting temperature observed in the ligand-bound
form.
These results from the modelling are again consistent with
changes in the spectrum observed upon ligand binding and
imply that the ligand leads to a modication in the interactions
between residues, as would be anticipated upon ‘locking’ the
enzyme structure into a particular conformation through
intermolecular interactions. It is also important that INH–NAD
binding does not have a uniform impact on the wild-type and
S94A mutant, the eﬀect being overall larger in the wild-type
enzyme than the S94A mutant, again consistent with the
experimental observations of an increased oﬀ-diagonal peak
amplitude in the wild-type enzyme.
In an eﬀort to shed light on the dynamic impact of co-factor
or inhibitor binding, MD simulations were carried out begin-
ning with the published crystal structures of the wild type
enzyme complexed with NADH (PDB 2aq8 (ref. 10)) and with
INH–NAD (PDB 1zid5). Simulations were performed on the
complete complex structure and on the apo structure, which
began from the same point but with the ligand excised from the
binding site. The process was repeated for the same two
complexes of the S94A mutant (PDB with NADH: 4dti;11 with
INH–NAD: 2nv6 (ref. 7)).
The results of this process are shown in Fig. 9. Each panel
shows a comparison of the root mean square uctuation
(RMSF) of each residue of a particular enzyme mutant/ligand
combination under apo (black solid line) and bound (dashed
line) conditions. The grey areas are marked to show regions of
interest and are identical across the four panels.
Notable residues obtained from biochemical or structural
studies are marked using asterisks. Specically, residues
located near the INH part of the INH–NAD complex (Y158, F149,
L207, I202, M199) are marked with black asterisks, while those
aﬀected by binding of NADH (16, 20, 41–44 and 95) are marked
green. The Y158, F149 and K165 residues that have been shown
to be key to function are marked with blue asterisks; Y158 and
F149 have both been shown to move when the adduct binds
with Y158 rotating towards the substrate binding loop. The
latter (marked SBL in Fig. 9) is the region of hel-6 near residue
200 that has been observed to undergo an order-disorder tran-
sition. F149 has been observed to rotate to form a stacking
Fig. 8 Coupling diﬀerence map (lower right quadrant) and contact
map (upper left quadrant) for (a) apo wild-type without inhibitor (PDB:
2aq8 (ref. 10)) and apo S94Amutant without inhibitor (PDB: 4dti11); and
(b) wild-type with inhibitor (PDB: 1zid5) and S94A mutant with inhibitor
(PDB: 2nv6 (ref. 7)). A structural contact between two residues is
depicted on the upper left quadrant of themap as a black square when
the Ca atoms of the residues are within 10 A˚ of each other. Only
interactions longer-range than i, i + 4 are shown. The lower right
quadrant shows changes in vibrational coupling. Colour-bar scales
depict the absolute diﬀerence in the coupling interaction energy
(cm1). Key regions of the structure are marked with boxes: orange:
cofactor binding site; red: NADH interactions; blue: substrate binding
loop.
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interaction with the INH ring of the adduct. The mutations that
have been observed to confer resistance in clinical isolates
(S94A, I21V and I47T) are marked with red asterisks. The co-
factor binding site is formed by str-4, str-5 and hel-5 plus
hel-6 and hel-7, which are also marked.
Upon binding the INH–NAD inhibitor to wild type InhA
(Fig. 9(a) solid line to dashed line), there is a general reduction
in RMSF across the residue sequence. This is more notable in
some regions of the structure than others but reductions in
spatial uctuations are predicted to occur near several of the
important residues involved in either co-factor binding (black
and green asterisks) or the portions of the InhA structure
involved in function (blue asterisks and SBL). Hel-4, str-5 and
hel-6, which contribute to the Rossmann fold, also experience
reduced uctuation upon ligand binding.
Comparing Fig. 9(a), for the inhibited wild-type complex to
Fig. 9(b), which compares the results of MD simulations of
RMSF for the wild-type-NADH complex with the apo-enzyme
shows several diﬀerences. In particular, the general reduction
in RMSF is not observed and the results for the ligand bound
and ligand free complex are rather similar except for a surface-
exposed residue, A154, in the NADH binding site and a portion
of hel-6, which appear to experience more uctuation.
Fig. 9(c) and (d) show the results for MD simulations of the
INH–NAD and NADH complexes of the S94A mutation of InhA
respectively. Here it is interesting to note that, in the case of the
S94A–INH–NAD complex (Fig. 9(c)), the binding of the ligand
has a less dramatic eﬀect than in the case of the corresponding
wild-type complex but appears to increase the RMSF rather than
decrease it as in the wild-type enzyme. This is particularly
notable in the NADH binding region near hel-4 and hel-5,
though the SBL is unaﬀected. Similar to the wild-type enzyme,
NADH binding to the S94A mutant seems to have a relatively
modest eﬀect on the predicted RMSF values.
In summary, MD simulations support the hypothesis that
binding of the inhibitor to the wild-type enzyme has consider-
ably more impact upon the dynamics of the key structural areas
of the enzyme than NADH binding, leading to a general loss of
exibility of the structure. In the case of the resistant mutation
S94A, this impact is apparently lost.
Overall, the combination of one-exciton Hamiltonian calcu-
lations and MD simulations suggest that the spectral changes
Fig. 9 Results of MD simulations showing RMSF values as a function of residue number using crystal structures as starting points: (a) wild type
InhA bound to INH–NAD, (b) wild type InhA bound to NADH, (c) S94A–InhA bound to INH–NAD, (d) S94A–InhA bound to NADH. In each panel,
the solid line represents the apo enzyme, with the substrate removed, the dashed line represents the enzyme with co-factor or inhibitor bound.
The horizontal lines are to guide the eye.
This journal is © The Royal Society of Chemistry 2017 Chem. Sci.
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observed in the 2D-IR data are linked to alterations in both the
vibrational interactions and dynamics of the enzyme upon
binding of co-factor and inhibitor. Binding of the co-factor
leads to an increased vibrational coupling of the Rossmann
fold residues in most cases, but binding the inhibitor leads to
a dynamic restriction of the wild-type structure that is not seen
in the S94A mutation.
Conclusions
Bringing together the experimental and computation simula-
tion results permits general conclusions to be drawn. The
overall indication is that the increased amplitude of the oﬀ-
diagonal feature observed in the 2D-IR spectroscopy upon
ligand binding is likely to be attributable to a general increase
in vibrational coupling occurring in the b–a–b Rossmann fold
caused by binding of the co-factor and that this enhances the
structural integrity of the b-sheet element of the structure,
which is observed in the 2D-IR spectra. We suggest the addi-
tional increase in amplitude observed in the INH–NAD complex
of the wild-type enzyme and W222A mutant that correlates with
inhibition is due to reductions in overall exibility of the
enzyme in the inhibited case further increasing these eﬀects.
Although site-specic information is not obtainable from the
2D-IR dataset, the impact of occupation of the co-factor binding
site upon both coupling changes and exibility in the S94A
mutant is markedly reduced, consistent with its function being
less impaired by binding of the INH–NAD inhibitor.
The implications for enzyme action are interesting because
the indication is that inhibition of wild-type InhA by INH–NAD
is caused by the ligand ‘locking’ the structure in such a manner
as to prevent function. This combines with the observation that
changes in coupling and exibility were not localised entirely to
the binding site but spread throughout the structure (Fig. 8 and
9). This agrees with observations that the function of InhA may
hinge upon its ability to form homo-tetramers or intermolecular
complexes with other enzymes in the FASII pathway.3,13,14 In the
inhibited wild-type case, the dynamic restriction imposed may
prevent conformational searching or the ability to form
a particular structure needed for this interaction. The more
exible S94A mutation can apparently circumvent this eﬀect.
This study demonstrates that 2D-IR is able to reveal the
subtleties of how binding of ligands to proteins leads to prolic
changes to the protein scaﬀold away from the intermolecular
contact site. These extended inuences are expected to have
important consequences for the overall structure and dynamics
that lead to securing contact. We hypothesise that they promote
drug eﬃcacy and a sealing oﬀ of activity of the enzyme, with
expected synergic eﬀects. This work clearly shows a way forward
to prove this hypothesis and characterise these synergic interac-
tions by combining 2D-IR spectroscopy and MD simulations to
address the problem of drug resistance in a systematic manner,
providing a new means to identify potential drug targets.
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